Reproductive Toxicity of DA-125, A New Anthracycline Anticancer Agent: Peri- and Postnatal Study in Rats

새로운 안트라사이클린계 항암제 DA-125의 생식독성연구: 랫트 주산기 및 수유기시험

  • 정문구 (한국화학연구소) ;
  • 이순복 (동아제약 주식회사 연구소) ;
  • 한상섭 (동아제약 주식회사 연구소) ;
  • 노정구 (동아제약 주식회사 연구소)
  • Published : 1995.03.01

Abstract

DA-125, a new anthracycline antitumor antibiotic, was administered at dose levels of 0, 0.04, 0.2 and 1.0 mg/kg/day intravenously to pregnant and subsequently delivered Sprague-Dawley rats from day 17 of gestation to day 21 of lactation. Effects of test agent on general toxicity of dams and growth, behaviour and mating performance of F1 offspring were examined. At 1 mg/kg, one out of the twentytwo dams showed difficult delivery, characterized by a stillbirth. Reduction in body weight, loss in food intake, and decrease in spleen weight were also observed in dams. In addition, the lower rates of successful performances in memory test (28.6%) and necrosis of tail end (9.5%) were seen in F1 offspring. At 0.04 and 0.2 mg/kg, no toxic effect on dams and F1 offspring was observed. There were no malformed Fl and F2 fetuses in all groups. The results indicate that the no effect dose levels(NOELs) of DA-125 are 0.2 mg/kg/day for dams and Fl offspring, and over 1 mg/kg/day for F2 fetuses.

Keywords